Singapur - İngilizce - HSA (Health Sciences Authority)

pfizer private limited - neisseria meningitidis group a polysaccharide; neisseria meningitidis group c polysaccharide; neisseria meningitidis group w-135 polysaccharide; neisseria meningitidis group y polysaccharide; tetanus toxoid carrier protein - injection, powder, for solution - 5 micrograms - neisseria meningitidis group a polysaccharide 5 micrograms; neisseria meningitidis group c polysaccharide 5 micrograms; neisseria meningitidis group w-135 polysaccharide 5 micrograms; neisseria meningitidis group y polysaccharide 5 micrograms; tetanus toxoid carrier protein ~44 micrograms

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - neisseria meningitidis group c strain c11 capsular polysaccharide tetanus toxoid conjugate; haemophilus influenzae type b polysaccharide tetanus toxoid conjugate - powder and solvent for solution for injection

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - haemophilus influenzae type b prp 5ug (conjugated with 12.5 mcg tetanus toxoid);  ; neisseria meningitidis group c polysaccharide 5ug (5 mcg men c polysaccharide conjugated to 5 mcg tetanus toxoid) - injection with diluent - 0.5 ml - active: haemophilus influenzae type b prp 5ug (conjugated with 12.5 mcg tetanus toxoid)   neisseria meningitidis group c polysaccharide 5ug (5 mcg men c polysaccharide conjugated to 5 mcg tetanus toxoid) excipient: sodium chloride sucrose tetanus toxoid trometamol hydrochloride sodium chloride water for injection - menitorix is indicated for the prevention of invasive diseases caused by haemophilus influenzae type b (hib) and neisseria meningitidis serogroup c (menc).

Avrupa Birliği - İngilizce - EMA (European Medicines Agency)

pfizer europe ma eeig - neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid - meningitis, meningococcal - vaccines - nimenrix is indicated for active immunisation of individuals from the age of 6 weeks against invasive meningococcal diseases caused by neisseria meningitidis group a, c, w-135, and y.

Filipinler - İngilizce - FDA (Food And Drug Administration)

pfizer, inc. - meningococcal groups a, c, w-135 and y conjugate vaccine - lyophilized powder for solution for injection (im) - formulation: after reconstitution, each dose (0.5 ml) contains: neisseria meningitidis group a polysaccharide* neisseria meningitidis group c polysaccharide* neisseria meningitidis group w-135 polysaccharide* neisseria meningitidis group y polysaccharide* 5 mcg 5 mcg 5 mcg 5 mcg * conjugated to tetanus toxoid carrier protein 44 mcg

Filipinler - İngilizce - FDA (Food And Drug Administration)

n/a; importer: sanofi pasteur, inc.; distributor: zuellig pharma corporation - meningococcal group a, c, w-135 and y conjugate vaccine - solution for injection (im) - formulation: each dose (0.5 ml) contains: neisseria meningitidis group a polysaccharide* .... 10 mcg neisseria meningitidis group c polysaccharide* .... 10 mcg neisseria meningitidis group y polysaccharide* .... 10 mcg neisseria meningitidis group w-135 polysaccharide* .... 10 mcg *conjugated to tetanus toxoid carrier protein... 55 mcg** **tetanus toxoid quantity is approximate and dependent on the polysaccharide to protein ratio for the conjugates in each formulation

Suudi Arabistan - İngilizce - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi pasteur - polysaccharide of neisseria meningitidis group a, polysaccharide of neisseria meningitidis group c - powder and solvent for suspension for injection - 50 , 50 µg

Suudi Arabistan - İngilizce - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi pasteur - polysaccharide of neisseria meningitidis group a, polysaccharide of neisseria meningitidis group c - powder and solvent for suspension for injection - 50 , 50 µg

Güney Afrika - İngilizce - South African Health Products Regulatory Authority (SAHPRA)

sanofi-aventis south africa (pty) ltd - solution - 10 μg & 55 μg - each 0,5 ml solution contains neisseria meningitidis group a polysaccharide 10,0 μg neisseria meningitidis group c polysaccharide 10,0 μg neisseria meningitidis group y polysaccharide 10,0 μg neisseria meningitidis group w polysaccharide 10,0 μg tetanus toxoid carrier protein 55,0 μg

Birleşik Krallık - İngilizce - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - neisseria meningitidis group c capsular polysaccharide; neisseria meningitidis group a capsular polysaccharide - powder and solvent for solution for injection